Kolltan Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Kolltan Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2088
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Kolltan Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Kolltan Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Kolltan Pharmaceuticals, Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Kolltan Pharmaceuticals, Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Kolltan Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Kolltan Pharmaceuticals, Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Kolltan Pharmaceuticals, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Kolltan Pharmaceuticals, Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Kolltan Pharmaceuticals, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 10
Partnership – Deal reports 10
CAPITAL RAISING 41
Capital Raising – Overview 41
Capital Raising – Deal reports 42
PRIVATE EQUITY & OWNERSHIP 57
Private Equity and Ownership – Overview 57
Private Equity and Ownership – Deal reports 58
APPENDIX 65
Contact Us 65
About MarketLine Financial Deals Database 65
Deal Definition and Methodology 67
About MarketLine 74

List of Tables
Table 1: Kolltan Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Table 2: Kolltan Pharmaceuticals M&A activity by geography (2014-YTD2018)
Table 3: Kolltan Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Table 4: Kolltan Pharmaceuticals capital raising by deal type (2014-YTD2018)
Table 5: Kolltan Pharmaceuticals private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Kolltan Pharmaceuticals private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Kolltan Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Figure 2: Kolltan Pharmaceuticals M&A activity by geography (2014-YTD2018)
Figure 3: Kolltan Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Figure 4: Kolltan Pharmaceuticals capital raising by deal type (2014-YTD2018)
Figure 5: Kolltan Pharmaceuticals private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Kolltan Pharmaceuticals private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Kolltan Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TOTVS SA:企業の戦略・SWOT・財務分析
    TOTVS SA - Strategy, SWOT and Corporate Finance Report Summary TOTVS SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Sasa Polyester Sanayi AS (SASA):企業の財務・戦略的SWOT分析
    Summary Sasa Polyester Sanayi AS (Sasa), formerly Advansa Sasa Polyester Sanayi AS, is a chemical company that produces filament yarns, polyester staple fibers, polyester-based and specialty polymers. The company offers products such as polyester elastomers, dimethyl terephthalate, advanite pbt solu …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Calix, Inc. (CALX):企業の財務・戦略的SWOT分析
    Calix, Inc. (CALX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Booz Allen Hamilton Holding Corporation:企業の戦略・SWOT・財務情報
    Booz Allen Hamilton Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Booz Allen Hamilton Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Approach Resources Inc. (AREX)-石油・ガス分野:企業M&A・提携分析
    Summary Approach Resources Inc. (Approach Resources) is an independent upstream oil and gas company. The company acquires oil and natural gas properties; and explores, develops and produces oil, natural gas and natural gas liquids (NGLs). It focuses on oil and gas reserves in oil shale and tight gas …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Soitec SA (SOI)-エネルギー分野:企業M&A・提携分析
    Summary Soitec S.A. (Soitec) is a designer and manufacturer of semiconductor materials. The company offers solutions for miniaturizing chips. Its products are used to manufacture chips which are used in smartphones, tablets, computers, IT servers and data centers, electronic components in cars, conn …
  • Avery Dennison Corporation (AVY)-医療機器分野:企業M&A・提携分析
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, radio-frequency identific …
  • MGB Biopharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds. Its lead drug candidate MGB-BP-3 in the field of antibacterial resistance is active against may Gram-positive bacteria. MGB Biopharma a …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SSY Group Ltd (2005):企業の財務・戦略的SWOT分析
    Summary SSY Group Ltd (SSY), Subsidiary of China Pharmaceutical Company Limited, is a pharmaceutical company that offers range of pharmaceutical products such as intravenous infusion solution. The company offers glass bottle infusion solutions, non-PVC soft bag infusions, and PP plastic bottle infus …
  • ChemRar High-Tech Center:製薬・医療:M&Aディール及び事業提携情報
    Summary ChemRar High-Tech Center (CHTC) is a developer of drugs for life-threatening diseases. The company offers drugs for the treatment of cancer, central nervous system, infectious, metabolic and cardiovascular diseases. It also offers pre-clinical and clinical research of new molecules including …
  • Bemis Company Inc (BMS):企業の財務・戦略的SWOT分析
    Bemis Company Inc (BMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務分析
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Baker & McKenzie LLP:企業の戦略的SWOT分析
    Baker & McKenzie LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Trinity Industries, Inc.:企業の戦略・SWOT・財務分析
    Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆